Table 5 Post-procedural data
Parameter | All (N = 16) | TAVR (N = 9) | SAVR (N = 7) |
|---|---|---|---|
Paravalvular leakage | |||
None | 15 (94%) | 8 (89%) | 7 (100%) |
Mild | 1 (6%) | 1 (11%) | 0 (0%) |
Severe | 0 (0%) | 0 (0%) | 0 (0%) |
Mean pressure gradient (mmHg) | 11 (9; 18) | 11 (7; 16) | 14.5 (11; 19) |
Diameter of valve prothesis (mm) | 25 (23; 26) | 26 (25; 29) | 23 (23; 24) |
LVEF (%) | 58 (55; 60) | 55 (45; 60) | 60 (58; 61) |
Length of hospital stay (days) | 29 (17; 63) | 31 (10; 61) | 27 (21; 67) |
Transfusion of packed red blood cells | 2 (0; 4) | 1 (0; 2) | 5 (3; 6) |
NYHA class after valve surgery / intervention | |||
I | 11 (69%) | 5 (56%) | 6 (86%) |
II | 1 (6%) | 1 (11%) | 0 (0%) |
III | 1 (6%) | 0 (0%) | 1 (14%) |
IV | 0 (0%) | 0 (0%) | 0 (0%) |
NA | 3 (19%) | 3 (33%) | 0 (0%) |
Subjective improvement | 10 (62%) | 5 (55%) | 5 (71%) |
Postoperative course | |||
Uneventful | 8 (50%) | 4 (44%) | 4 (57%) |
Stroke | 2 (13%) | 1 (11%) | 1 (14%) |
Pacemaker implantation | 1 (6%) | 1 (11%) | 0 (0%) |
Access site complication | 1 (6%) | 1 (11%) | 0 (0%) |
MCS | 2 (13%) | 0 (0%) | 2 (29%) |
Postoperative infection | 4 (25%) | 3 (33%) | 1 (14%) |
